Determining the Willingness to Pay for Innovative Oncology Medicines in Malaysia

Objectives: Early access to innovative oncology medicine is crucial to provide better treatment alternatives to patients with cancer. However, innovative oncology medicines often come at higher prices, thus limiting the government's ability for its universal coverage. Hence an alternative payin...

Full description

Bibliographic Details
Published in:Value in Health Regional Issues
Main Author: Dzulkipli M.R.; Shafie A.A.; Maon S.N.; Ramli A.; Yahaya A.H.M.; Ho S.W.; Muhsin N.I.A.; Ahmat A.N.M.F.
Format: Article
Language:English
Published: Elsevier Inc. 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85176916471&doi=10.1016%2fj.vhri.2023.10.003&partnerID=40&md5=1b2c942bd53b6aa14d322514dede6b94